c-Abl is clinically important as the constitutively-active kinase in the oncogenic fusion protein BCR-ABL1 in chronic myelogenous leukemia and in some acute lymphoblastic leukemias [28], [29]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.